Cortical changes associated with depression and antidepressant use in alzheimer and lewy body dementia: An MRI surface-based morphometric study

American Journal of Geriatric Psychiatry

Volumn 22, Issue 1, 2014, Pages

  Lebedev, Alexander V ^a   Beyer, Mona K ^b   Fritze, Friederike ^a   Westman, Eric ^c   Ballard, Clive ^d   Aarsland, Dag ^a,b  

^a STAVANGER UNIVERSITY HOSPITAL   (Norway)

^b OSLO UNIVERSITY HOSPITAL   (Norway)

^c KAROLINSKA INSTITUTE   (Sweden)

^d KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Antidepressants; Cortical thickness; Dementia; Depression; Surface based morphometry

Indexed keywords

ANTIDEPRESSANT AGENT; CLOMIPRAMINE; SEROTONIN UPTAKE INHIBITOR;

AGED; ALZHEIMER DISEASE; ARTICLE; CORTICAL THICKNESS (BRAIN); DEPRESSION; DIFFUSE LEWY BODY DISEASE; DISEASE ASSOCIATION; FEMALE; GERONTOPSYCHIATRY; GRAY MATTER; HUMAN; IMAGE PROCESSING; IMAGE RECONSTRUCTION; MAJOR CLINICAL STUDY; MALE; MONTGOMERY ASBERG DEPRESSION RATING SCALE; MORPHOMETRICS; NEUROIMAGING; NORWAY; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SCANNER; OUTPATIENT DEPARTMENT; PARAHIPPOCAMPAL GYRUS; PREFRONTAL CORTEX; TEMPORAL CORTEX; VERY ELDERLY; WHITE MATTER; ATROPHY; BRAIN CORTEX; CHEMICALLY INDUCED; COMPLICATION; LEWY BODY DISEASE; PATHOLOGY;

AGED; ALZHEIMER DISEASE; ANTIDEPRESSIVE AGENTS; ATROPHY; CEREBRAL CORTEX; DEPRESSION; FEMALE; HUMANS; LEWY BODY DISEASE; MAGNETIC RESONANCE IMAGING; MALE; NEUROIMAGING;

EID: 84893406483     PISSN: 10647481     EISSN: 15457214     Source Type: Journal    
DOI: 10.1016/j.jagp.2013.02.004     Document Type: Article

References (76)

1. Fritze F, Ehrt U, Sonnesyn H, et al: Depression in mild dementia: associations with diagnosis, APOE genotype and clinical features. Int J Geriatr Psychiatry 2011; 26:1054-1061
2. Aarsland D, Bronnick K, Ehrt U, et al: Neuropsychiatric symptoms in patients with Parkinson's disease and dementia: frequency, profile and associated care giver stress. J Neurol Neurosurg Psychiatry 2007; 78:36-42
3. Ballard CG, Eastwood C, Gahir M, et al: A follow up study of depression in the carers of dementia sufferers. BMJ 1996; 312: 947
4. Lyketsos CG, Steele C, Baker L, et al: Major and minor depression in Alzheimer's disease: prevalence and impact. J Neuropsychiatry Clin Neurosci 1997; 9:556-561
5. Enache D, Winblad B, Aarsland D: Depression in dementia: epidemiology, mechanisms, and treatment. Curr Opin Psychiatry 2011; 24:461-472
6. Reifler BV, Larson E, Hanley R: Coexistence of cognitive impairment and depression in geriatric outpatients. Am J Psychiatry 1982; 139:623-626
7. Merriam AE, Aronson MK, Gaston P, et al: The psychiatric symptoms of Alzheimer's disease. J Am Geriatr Soc 1988; 36: 7-12
8. Leonard BE, Myint A: Changes in the immune system in depression and dementia: causal or coincidental effects? Dialogues Clin Neurosci 2006; 8:163-174
9. Lai T, Payne ME, Byrum CE, et al: Reduction of orbital frontal cortex volume in geriatric depression. Biol Psychiatry 2000; 48: 971-975
10. MacFall JR, Payne ME, Provenzale JE, et al: Medial orbital frontal lesions in lateeonset depression. Biol Psychiatry 2001; 49: 803-806
11. Lavretsky H, Roybal DJ, Ballmaier M, et al: Antidepressant exposure may protect against decrement in frontal gray matter volumes in geriatric depression. J Clin Psychiatry 2005; 66: 964-967
12. Colloby SJ, Firbank MJ, Vasudev A, et al: Cortical thickness and VBM-DARTEL in late-life depression. J Affect Disord 2011; 133: 158-164
13. Rajkowska G, Miguel-Hidalgo JJ, Dubey P, et al: Prominent reduction in pyramidal neurons density in the orbitofrontal cortex of elderly depressed patients. Biol Psychiatry 2005; 58:297-306
14. Lim HK, Jung WS, Ahn KJ, et al: Regional cortical thickness and subcortical volume changes are associated with cognitive impairments in the drug-naive patients with late-onset depression. Neuropsychopharmacology 2012; 37:838-849
15. Starkstein SE, Mizrahi R, Capizzano AA, et al: Neuroimaging correlates of apathy and depression in Alzheimer's disease. J Neuropsychiatry Clin Neurosci 2009; 21:259-265
16. Soennesyn H, Oppedal K, Greve O, et al: White matter hyperintensities and the course of depressive symptoms in elderly people with mild dementia. Dement Geriatr Cogn Disord 2012; 2: 97-111
17. Vermetten E, Vythilingam M, Southwick SM, et al: Long-term treatment with paroxetine increases verbal declarative memory and hippocampal volume in posttraumatic stress disorder. Biol Psychiatry 2003; 54:693-702
18. Frodl T, Jager M, Smajstrlova I, et al: Effect of hippocampal and amygdala volumes on clinical outcomes in major depression: a 3- year prospective magnetic resonance imaging study. J Psychiatry Neurosci 2008; 33:423-430
19. Steffens DC, Chung H, Krishnan KR, et al: Antidepressant treatment and worsening white matter on serial cranial magnetic resonance imaging in the elderly: the Cardiovascular Health Study. Stroke 2008; 39:857-862
20. Geerlings MI, Brickman AM, Schupf N, et al: Depressive symptoms, antidepressant use, and brain volumes on MRI in a population- based cohort of old persons without dementia. J Alzheimers Dis 2012; 30:75-82
21. Banerjee S, Hellier J, Dewey M, et al: Sertraline or mirtazapine for depression in dementia (HTA-SADD): a randomised, multicentre, double-blind, placebo-controlled trial. Lancet 2011; 378: 403-411
22. Aarsland D, Rongve A, Nore SP, et al: Frequency and case identification of dementia with Lewy bodies using the revised consensus criteria. Dement Geriatr Cogn Disord 2008; 26:445-452
23. McKhann G, Drachman D, Folstein M, et al: Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984; 34:939-944
24. McKeith IG, Dickson DW, Lowe J, et al: Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium. Neurology 2005; 65:1863-1872
25. Emre M, Aarsland D, Brown R, et al: Clinical diagnostic criteria for dementia associated with Parkinson's disease. Mov Disord 2007; 22:1689-1707; quiz 1837
26. Jorm AF, Jacomb PA: The Informant Questionnaire on Cognitive Decline in the Elderly (IQCODE): socio-demographic correlates, reliability, validity and some norms. Psychol Med 1989; 19: 1015-1022
27. Morris JC: Clinical dementia rating: a reliable and valid diagnostic and staging measure for dementia of the Alzheimer type. Int Psychogeriatr 1997; 9(suppl 1):173-176; discussion 177-178
28. Fahn S, Elton R, Committee UD: Unified Parkinson's Disease Rating Scale. Recent Developments in Parkinson's Disease. Florham Park, NJ, Macmillan, 1987
29. McKeith I, O'Brien J, Walker Z, et al: Sensitivity and specificity of dopamine transporter imaging with 123I-FP-CIT SPECT in dementia with Lewy bodies: a phase III, multicentre study. Lancet Neurol 2007; 6:305-313
30. Montgomery SA, Asberg M: A new depression scale designed to be sensitive to change. Br J Psychiatry 1979; 134:382-389
31. Muller-Thomsen T, Arlt S, Mann U, et al: Detecting depression in Alzheimer's disease: evaluation of four different scales. Arch Clin Neuropsychol 2005; 20:271-276
32. Knapskog AB, Barca ML, Engedal K: A comparison of the validity of the Cornell Scale and the MADRS in detecting depression among memory clinic patients. Dem Ger Cogn Disord 2011; 32:287-294
33. Revelle W: psych: Procedures for Personality and Psychological Research. Northwestern University, Evanston. R package version 1.2.8. (online). Available at: http://CRAN.R-project.org/package=psych. 2012.Accessed April 24, 2013
34. R Development Core Team. R: A Language and Environment for Statistical Computing. Vienna, Austria, R Foundation for Statistical Computing, 2011
35. Han X, Jovicich J, Salat D, et al: Reliability of MRI-derived measurements of human cerebral cortical thickness: the effects of field strength, scanner upgrade and manufacturer. Neuroimage 2006; 32:180-194
36. Segonne F, Dale AM, Busa E, et al: A hybrid approach to the skull stripping problem in MRI. Neuroimage 2004; 22:1060-1075
37. Sled JG, Zijdenbos AP, Evans AC: A nonparametric method for automatic correction of intensity nonuniformity in MRI data. IEEE Trans Med Imaging 1998; 17:87-97
38. Segonne F, Pacheco J, Fischl B: Geometrically accurate topologycorrection of cortical surfaces using nonseparating loops. IEEE Trans Med Imaging 2007; 26:518-529
39. Dale AM, Fischl B, Sereno MI: Cortical surface-based analysis. I. Segmentation and surface reconstruction. Neuroimage 1999; 9: 179-194
40. Fischl B, Dale AM: Measuring the thickness of the human cerebral cortex from magnetic resonance images. Proc Natl Acad Sci USA 2000; 97:11050-11055
41. Fischl B, Sereno MI, Dale AM: Cortical surface-based analysis. II: Inflation, flattening, and a surface-based coordinate system. Neuroimage 1999; 9:195-207
42. Fischl B, Sereno MI, Tootell RB, et al: High-resolution intersubject averaging and a coordinate system for the cortical surface. Hum Brain Mapp 1999; 8:272-284
43. Desikan RS, Segonne F, Fischl B, et al: An automated labeling system for subdividing the human cerebral cortex on MRI scans into gyral based regions of interest. Neuroimage 2006; 31:968-980
44. Fischl B, van der Kouwe A, Destrieux C, et al: Automatically parcellating the human cerebral cortex. Cereb Cortex 2004; 14: 11-22
45. Rosas HD, Liu AK, Hersch S, et al: Regional and progressive thinning of the cortical ribbon in Huntington's disease. Neurology 2002; 58:695-701
46. Kuperberg GR, Broome MR, McGuire PK, et al: Regionally localized thinning of the cerebral cortex in schizophrenia. Arch Gen Psychiatry 2003; 60:878-888
47. Salat DH, Buckner RL, Snyder AZ, et al: Thinning of the cerebral cortex in aging. Cereb Cortex 2004; 14:721-730
48. Esbensen KH, Guyot D, Westad F, et al: Multivariate Data Analysis in Practice: An Introduction to Multivariate Data Analysis and Experimental Design. 5th ed. Esbjerg, Aalborg University, 2002
49. Hagler DJ Jr, Saygin AP, Sereno MI: Smoothing and cluster thresholding for cortical surface-based group analysis of fMRI data. Neuroimage 2006; 33:1093-1103
50. Hayasaka S, Nichols TE: Validating cluster size inference: random field and permutation methods. Neuroimage 2003; 20:2343-2356
51. Ward BD: Simultaneous Inference for FMRI Data. AFNI 3dDeconvolve Documentation. Milwaukee, WI, Medical College of Wisconsin, 2000
52. Alexander GE, DeLong MR, Strick PL: Parallel organization of functionally segregated circuits linking basal ganglia and cortex. Annu Rev Neurosci 1986; 9:357-381
53. Cummings JL: Frontal-subcortical circuits and human behavior. Arch Neurol 1993; 50:873-880
54. Mega MS, Cummings JL: Frontal-subcortical circuits and neuropsychiatric disorders. J Neuropsychiatry Clin Neurosci 1994; 6: 358-370
55. Tekin S, Cummings JL: Frontal-subcortical neuronal circuits and clinical neuropsychiatry: an update. J Psychosom Res 2002; 53: 647-654
56. Mayberg HS: Modulating dysfunctional limbic-cortical circuits in depression: towards development of brain-based algorithms for diagnosis and optimised treatment. Br Med Bull 2003; 65:193-207
57. Drevets WC, Price JL, Furey ML: Brain structural and functional abnormalities in mood disorders: implications for neurocircuitry models of depression. Brain Struct Funct 2008; 213: 93-118
58. Kostic VS, Agosta F, Petrovic I, et al: Regional patterns of brain tissue loss associated with depression in Parkinson disease. Neurology 2010; 75:857-863
59. Benesova Y, Niedermayerova I, Mechl M, et al: The relation between brain MRI lesions and depressive symptoms in multiple sclerosis. Bratisl Lek Listy 2003; 104(4-5):174-176
60. Feinstein A, Roy P, Lobaugh N, et al: Structural brain abnormalities in multiple sclerosis patients with major depression. Neurology 2004; 62:586-590
61. Mayberg HS, Starkstein SE, Sadzot B, et al: Selective hypometabolism in the inferior frontal lobe in depressed patients with Parkinson's disease. Ann Neurol 1990; 28:57-64
62. Ring HA, Bench CJ, Trimble MR, et al: Depression in Parkinson's disease.Apositron emission study. Br J Psychiatry 1994; 165:333-339
63. Mayberg HS, Starkstein SE, Peyser CE, et al: Paralimbic frontal lobe hypometabolism in depression associated with Huntington's disease. Neurology 1992; 42:1791-1797
64. Taylor WD, MacFall JR, Payne ME, et al: Late-life depression and microstructural abnormalities in dorsolateral prefrontal cortex white matter. Am J Psychiatry 2004; 161:1293-1296
65. Nobuhara K, Okugawa G, Minami T, et al: Effects of electroconvulsive therapy on frontal white matter in late-life depression: a diffusion tensor imaging study. Neuropsychobiology 2004; 50: 48-53
66. Nobuhara K, Okugawa G, Sugimoto T, et al: Frontal white matter anisotropy and symptom severity of late-life depression: a magnetic resonance diffusion tensor imaging study. J Neurol Neurosurg Psychiatry 2006; 77:120-122
67. Yang Q, Huang X, Hong N, et al: White matter microstructural abnormalities in late-life depression. Int Psychogeriatr 2007; 19:757-766
68. Murphy CF, Gunning-Dixon FM, Hoptman MJ, et al: White-matter integrity predicts Stroop performance in patients with geriatric depression. Biol Psychiatry 2007; 1:1007-1010
69. Shimony JS, Sheline YI, D'Angelo G, et al: Diffuse microstructural abnormalities of normal-appearingwhitematter in late life depression: a diffusion tensor imaging study. Biol Psychiatry 2009; 66:245-252
70. Starkstein SE, Vazquez S, Migliorelli R: A SPECT study of depression in Alzheimer's disease. Neuropsychiatry Neuropsychol Behav Neurol 1995; 8:38-43
71. Ebmeier KP, Glabus MF, Prentice N, et al: A voxel-based analysis of cerebral perfusion in dementia and depression of old age. Neuroimage 1998; 7:199-208
72. Staffen W, Bergmann J, Schonauer U, et al: Cerebral perfusion (HMPAO-SPECT) in patients with depression with cognitive impairment versus those with mild cognitive impairment and dementia of Alzheimer's type: a semiquantitative and automated evaluation. Eur J Nucl Med Mol Imaging 2009; 36: 801-810
73. Hickie IB, Naismith SL, Norrie LM, et al: Managing depression across the life cycle: new strategies for clinicians and their patients. Intern Med J 2009; 39:720-727
74. Coupland C, Dhiman P, Morriss R, et al: Antidepressant use and risk of adverse outcomes in older people: population based cohort study. BMJ 2011; 343:d4551
75. Sheline YI, Disabato BM, Hranilovich J, et al: Treatment course with antidepressant therapy in late-life depression. Am J Psychiatry 2012; 169(11):1185-1193
76. Olin JT, Katz IR, Meyers BS, et al: Provisional diagnostic criteria for depression of Alzheimer disease: rationale and background. Am J Geriatr Psychiatry 2002; 10:129-141